Insulet: Undisclosed patient deaths, risks to children, near-term competitive threats confirmed by close competitor and ...

In the past two weeks we have published three reports on Insulet Corporation (PODD). Today we also announced a the beginning of our campaign to inform regulatory and legal authorities of the severity of the issues we have uncovered. Some regulatory investigative effort is already underway at the FDA. We expect more action from the regulators and legal authorities soon. Our reports and letter to the Mass AG can be viewed at the following links.

http://skytides.com/research 
http://skytides.com/article/insulet-podd-november-21-2016-letter-massachusetts-attorney-general